J HEART LUNG TRANSPL 润色咨询

JOURNAL OF HEART AND LUNG TRANSPLANTATION

出版年份：1991 年文章数：1673 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：9.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1060349, encodeId=5c0e1060349f8, content=有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Thu Oct 14 09:34:40 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220569, encodeId=a5b4122056918, content=偏重的研究方向：移植免疫<br>经验分享：一审挺快，二审有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Tue May 17 23:18:34 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093291, encodeId=55b0109329194, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093292, encodeId=5072109329281, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589473, encodeId=b5e55894e359, content=？？？<span class="quote">orthomh 2011-06-28 16:05:00 发表:<br></span>, beContent=orthomh 2011-06-28 16:05:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=652, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477499, encodeId=92d94e749905, content=偏重的研究方向：植物学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=965, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee6d29181, createdName=orthomh, createdTime=Tue Jun 28 16:05:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2021-10-14 12034ee7m92暂无昵称

    有点慢啊

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1060349, encodeId=5c0e1060349f8, content=有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Thu Oct 14 09:34:40 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220569, encodeId=a5b4122056918, content=偏重的研究方向：移植免疫<br>经验分享：一审挺快，二审有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Tue May 17 23:18:34 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093291, encodeId=55b0109329194, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093292, encodeId=5072109329281, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589473, encodeId=b5e55894e359, content=？？？<span class="quote">orthomh 2011-06-28 16:05:00 发表:<br></span>, beContent=orthomh 2011-06-28 16:05:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=652, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477499, encodeId=92d94e749905, content=偏重的研究方向：植物学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=965, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee6d29181, createdName=orthomh, createdTime=Tue Jun 28 16:05:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2022-05-17 12034ee7m92暂无昵称

    偏重的研究方向：移植免疫
    经验分享：一审挺快，二审有点慢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1060349, encodeId=5c0e1060349f8, content=有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Thu Oct 14 09:34:40 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220569, encodeId=a5b4122056918, content=偏重的研究方向：移植免疫<br>经验分享：一审挺快，二审有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Tue May 17 23:18:34 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093291, encodeId=55b0109329194, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093292, encodeId=5072109329281, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589473, encodeId=b5e55894e359, content=？？？<span class="quote">orthomh 2011-06-28 16:05:00 发表:<br></span>, beContent=orthomh 2011-06-28 16:05:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=652, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477499, encodeId=92d94e749905, content=偏重的研究方向：植物学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=965, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee6d29181, createdName=orthomh, createdTime=Tue Jun 28 16:05:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    什么是letter?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1060349, encodeId=5c0e1060349f8, content=有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Thu Oct 14 09:34:40 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220569, encodeId=a5b4122056918, content=偏重的研究方向：移植免疫<br>经验分享：一审挺快，二审有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Tue May 17 23:18:34 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093291, encodeId=55b0109329194, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093292, encodeId=5072109329281, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589473, encodeId=b5e55894e359, content=？？？<span class="quote">orthomh 2011-06-28 16:05:00 发表:<br></span>, beContent=orthomh 2011-06-28 16:05:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=652, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477499, encodeId=92d94e749905, content=偏重的研究方向：植物学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=965, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee6d29181, createdName=orthomh, createdTime=Tue Jun 28 16:05:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    什么是comment？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1060349, encodeId=5c0e1060349f8, content=有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Thu Oct 14 09:34:40 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220569, encodeId=a5b4122056918, content=偏重的研究方向：移植免疫<br>经验分享：一审挺快，二审有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Tue May 17 23:18:34 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093291, encodeId=55b0109329194, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093292, encodeId=5072109329281, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589473, encodeId=b5e55894e359, content=？？？<span class="quote">orthomh 2011-06-28 16:05:00 发表:<br></span>, beContent=orthomh 2011-06-28 16:05:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=652, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477499, encodeId=92d94e749905, content=偏重的研究方向：植物学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=965, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee6d29181, createdName=orthomh, createdTime=Tue Jun 28 16:05:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2020-04-22 146f6ef6m90(暂无昵称)

    ？？？orthomh 2011-06-28 16:05:00 发表:

    orthomh 2011-06-28 16:05:00 发表:

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1060349, encodeId=5c0e1060349f8, content=有点慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Thu Oct 14 09:34:40 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220569, encodeId=a5b4122056918, content=偏重的研究方向：移植免疫<br>经验分享：一审挺快，二审有点慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2b302162386, createdName=12034ee7m92暂无昵称, createdTime=Tue May 17 23:18:34 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093291, encodeId=55b0109329194, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093292, encodeId=5072109329281, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589473, encodeId=b5e55894e359, content=？？？<span class="quote">orthomh 2011-06-28 16:05:00 发表:<br></span>, beContent=orthomh 2011-06-28 16:05:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=652, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477499, encodeId=92d94e749905, content=偏重的研究方向：植物学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=965, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee6d29181, createdName=orthomh, createdTime=Tue Jun 28 16:05:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2011-06-28 orthomh

    偏重的研究方向：植物学;

    0

共13条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分